Global Biosimilars/Follow-on-Biologics Market Growth 2023-2028

Report ID: 1157094 | Published Date: Jan 2025 | No. of Page: 104 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Biosimilars/Follow-on-Biologics by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Biosimilars/Follow-on-Biologics by Country/Region, 2017, 2022 & 2028
    2.2 Biosimilars/Follow-on-Biologics Segment by Type
        2.2.1 Human Growth Hormone
        2.2.2 Erythropoietin
        2.2.3 Monoclonal Antibodies
        2.2.4 Insulin
        2.2.5 Interferon
        2.2.6 Granulocyte-Colony Stimulating Factor
        2.2.7 Peptide
        2.2.8 Others
    2.3 Biosimilars/Follow-on-Biologics Sales by Type
        2.3.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
        2.3.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Type (2017-2022)
    2.4 Biosimilars/Follow-on-Biologics Segment by Application
        2.4.1 Blood Disorders
        2.4.2 Oncology Diseases
        2.4.3 Chronic and Autoimmune Diseases
        2.4.4 Growth Hormone Deficiencies
        2.4.5 Others
    2.5 Biosimilars/Follow-on-Biologics Sales by Application
        2.5.1 Global Biosimilars/Follow-on-Biologics Sale Market Share by Application (2017-2022)
        2.5.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Biosimilars/Follow-on-Biologics Sale Price by Application (2017-2022)
3 Global Biosimilars/Follow-on-Biologics by Company
    3.1 Global Biosimilars/Follow-on-Biologics Breakdown Data by Company
        3.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Company (2020-2022)
        3.1.2 Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2020-2022)
    3.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Company (2020-2022)
        3.2.1 Global Biosimilars/Follow-on-Biologics Revenue by Company (2020-2022)
        3.2.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2020-2022)
    3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Company
    3.4 Key Manufacturers Biosimilars/Follow-on-Biologics Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Biosimilars/Follow-on-Biologics Product Location Distribution
        3.4.2 Players Biosimilars/Follow-on-Biologics Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biosimilars/Follow-on-Biologics by Geographic Region
    4.1 World Historic Biosimilars/Follow-on-Biologics Market Size by Geographic Region (2017-2022)
        4.1.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Geographic Region
    4.2 World Historic Biosimilars/Follow-on-Biologics Market Size by Country/Region (2017-2022)
        4.2.1 Global Biosimilars/Follow-on-Biologics Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Biosimilars/Follow-on-Biologics Annual Revenue by Country/Region
    4.3 Americas Biosimilars/Follow-on-Biologics Sales Growth
    4.4 APAC Biosimilars/Follow-on-Biologics Sales Growth
    4.5 Europe Biosimilars/Follow-on-Biologics Sales Growth
    4.6 Middle East & Africa Biosimilars/Follow-on-Biologics Sales Growth
5 Americas
    5.1 Americas Biosimilars/Follow-on-Biologics Sales by Country
        5.1.1 Americas Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)
        5.1.2 Americas Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)
    5.2 Americas Biosimilars/Follow-on-Biologics Sales by Type
    5.3 Americas Biosimilars/Follow-on-Biologics Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Biosimilars/Follow-on-Biologics Sales by Region
        6.1.1 APAC Biosimilars/Follow-on-Biologics Sales by Region (2017-2022)
        6.1.2 APAC Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022)
    6.2 APAC Biosimilars/Follow-on-Biologics Sales by Type
    6.3 APAC Biosimilars/Follow-on-Biologics Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Biosimilars/Follow-on-Biologics by Country
        7.1.1 Europe Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)
        7.1.2 Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)
    7.2 Europe Biosimilars/Follow-on-Biologics Sales by Type
    7.3 Europe Biosimilars/Follow-on-Biologics Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Biosimilars/Follow-on-Biologics by Country
        8.1.1 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022)
    8.2 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type
    8.3 Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics
    10.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
    10.4 Industry Chain Structure of Biosimilars/Follow-on-Biologics
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Biosimilars/Follow-on-Biologics Distributors
    11.3 Biosimilars/Follow-on-Biologics Customer
12 World Forecast Review for Biosimilars/Follow-on-Biologics by Geographic Region
    12.1 Global Biosimilars/Follow-on-Biologics Market Size Forecast by Region
        12.1.1 Global Biosimilars/Follow-on-Biologics Forecast by Region (2023-2028)
        12.1.2 Global Biosimilars/Follow-on-Biologics Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Biosimilars/Follow-on-Biologics Forecast by Type
    12.7 Global Biosimilars/Follow-on-Biologics Forecast by Application
13 Key Players Analysis
    13.1 Novartis
        13.1.1 Novartis Company Information
        13.1.2 Novartis Biosimilars/Follow-on-Biologics Product Offered
        13.1.3 Novartis Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Novartis Main Business Overview
        13.1.5 Novartis Latest Developments
    13.2 Synthon Pharmaceuticals
        13.2.1 Synthon Pharmaceuticals Company Information
        13.2.2 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Offered
        13.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Synthon Pharmaceuticals Main Business Overview
        13.2.5 Synthon Pharmaceuticals Latest Developments
    13.3 Teva Pharmaceutical Industries
        13.3.1 Teva Pharmaceutical Industries Company Information
        13.3.2 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Offered
        13.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Teva Pharmaceutical Industries Main Business Overview
        13.3.5 Teva Pharmaceutical Industries Latest Developments
    13.4 LG Life Sciences
        13.4.1 LG Life Sciences Company Information
        13.4.2 LG Life Sciences Biosimilars/Follow-on-Biologics Product Offered
        13.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 LG Life Sciences Main Business Overview
        13.4.5 LG Life Sciences Latest Developments
    13.5 Celltrion
        13.5.1 Celltrion Company Information
        13.5.2 Celltrion Biosimilars/Follow-on-Biologics Product Offered
        13.5.3 Celltrion Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Celltrion Main Business Overview
        13.5.5 Celltrion Latest Developments
    13.6 Biocon
        13.6.1 Biocon Company Information
        13.6.2 Biocon Biosimilars/Follow-on-Biologics Product Offered
        13.6.3 Biocon Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Biocon Main Business Overview
        13.6.5 Biocon Latest Developments
    13.7 Hospira
        13.7.1 Hospira Company Information
        13.7.2 Hospira Biosimilars/Follow-on-Biologics Product Offered
        13.7.3 Hospira Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Hospira Main Business Overview
        13.7.5 Hospira Latest Developments
    13.8 Merck Group
        13.8.1 Merck Group Company Information
        13.8.2 Merck Group Biosimilars/Follow-on-Biologics Product Offered
        13.8.3 Merck Group Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Merck Group Main Business Overview
        13.8.5 Merck Group Latest Developments
    13.9 Biogen idec, Inc.
        13.9.1 Biogen idec, Inc. Company Information
        13.9.2 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Offered
        13.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Biogen idec, Inc. Main Business Overview
        13.9.5 Biogen idec, Inc. Latest Developments
    13.10 Genentech (Roche Group)
        13.10.1 Genentech (Roche Group) Company Information
        13.10.2 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Offered
        13.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Genentech (Roche Group) Main Business Overview
        13.10.5 Genentech (Roche Group) Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Biosimilars/Follow-on-Biologics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Biosimilars/Follow-on-Biologics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Human Growth Hormone
    Table 4. Major Players of Erythropoietin
    Table 5. Major Players of Monoclonal Antibodies
    Table 6. Major Players of Insulin
    Table 7. Major Players of Interferon
    Table 8. Major Players of Granulocyte-Colony Stimulating Factor
    Table 9. Major Players of Peptide
    Table 10. Major Players of Others
    Table 11. Global Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
    Table 12. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
    Table 13. Global Biosimilars/Follow-on-Biologics Revenue by Type (2017-2022) & ($ million)
    Table 14. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2017-2022)
    Table 15. Global Biosimilars/Follow-on-Biologics Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 16. Global Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
    Table 17. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
    Table 18. Global Biosimilars/Follow-on-Biologics Revenue by Application (2017-2022)
    Table 19. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2017-2022)
    Table 20. Global Biosimilars/Follow-on-Biologics Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 21. Global Biosimilars/Follow-on-Biologics Sales by Company (2020-2022) & (K Pcs)
    Table 22. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2020-2022)
    Table 23. Global Biosimilars/Follow-on-Biologics Revenue by Company (2020-2022) ($ Millions)
    Table 24. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2020-2022)
    Table 25. Global Biosimilars/Follow-on-Biologics Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 26. Key Manufacturers Biosimilars/Follow-on-Biologics Producing Area Distribution and Sales Area
    Table 27. Players Biosimilars/Follow-on-Biologics Products Offered
    Table 28. Biosimilars/Follow-on-Biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 29. New Products and Potential Entrants
    Table 30. Mergers & Acquisitions, Expansion
    Table 31. Global Biosimilars/Follow-on-Biologics Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 32. Global Biosimilars/Follow-on-Biologics Sales Market Share Geographic Region (2017-2022)
    Table 33. Global Biosimilars/Follow-on-Biologics Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 34. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Geographic Region (2017-2022)
    Table 35. Global Biosimilars/Follow-on-Biologics Sales by Country/Region (2017-2022) & (K Pcs)
    Table 36. Global Biosimilars/Follow-on-Biologics Sales Market Share by Country/Region (2017-2022)
    Table 37. Global Biosimilars/Follow-on-Biologics Revenue by Country/Region (2017-2022) & ($ millions)
    Table 38. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Country/Region (2017-2022)
    Table 39. Americas Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
    Table 40. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)
    Table 41. Americas Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)
    Table 42. Americas Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)
    Table 43. Americas Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
    Table 44. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
    Table 45. Americas Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
    Table 46. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
    Table 47. APAC Biosimilars/Follow-on-Biologics Sales by Region (2017-2022) & (K Pcs)
    Table 48. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2022)
    Table 49. APAC Biosimilars/Follow-on-Biologics Revenue by Region (2017-2022) & ($ Millions)
    Table 50. APAC Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2017-2022)
    Table 51. APAC Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
    Table 52. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
    Table 53. APAC Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
    Table 54. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
    Table 55. Europe Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
    Table 56. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)
    Table 57. Europe Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)
    Table 58. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)
    Table 59. Europe Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
    Table 60. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
    Table 61. Europe Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
    Table 62. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
    Table 63. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Country (2017-2022) & (K Pcs)
    Table 64. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country (2017-2022)
    Table 65. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue by Country (2017-2022) & ($ Millions)
    Table 66. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2017-2022)
    Table 67. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Type (2017-2022) & (K Pcs)
    Table 68. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Type (2017-2022)
    Table 69. Middle East & Africa Biosimilars/Follow-on-Biologics Sales by Application (2017-2022) & (K Pcs)
    Table 70. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
    Table 71. Key Market Drivers & Growth Opportunities of Biosimilars/Follow-on-Biologics
    Table 72. Key Market Challenges & Risks of Biosimilars/Follow-on-Biologics
    Table 73. Key Industry Trends of Biosimilars/Follow-on-Biologics
    Table 74. Biosimilars/Follow-on-Biologics Raw Material
    Table 75. Key Suppliers of Raw Materials
    Table 76. Biosimilars/Follow-on-Biologics Distributors List
    Table 77. Biosimilars/Follow-on-Biologics Customer List
    Table 78. Global Biosimilars/Follow-on-Biologics Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 79. Global Biosimilars/Follow-on-Biologics Sales Market Forecast by Region
    Table 80. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Region (2023-2028)
    Table 82. Americas Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 83. Americas Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. APAC Biosimilars/Follow-on-Biologics Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 85. APAC Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 86. Europe Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 87. Europe Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 88. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 89. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 90. Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 91. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Type (2023-2028)
    Table 92. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 93. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Type (2023-2028)
    Table 94. Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 95. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Application (2023-2028)
    Table 96. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 97. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Application (2023-2028)
    Table 98. Novartis Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 99. Novartis Biosimilars/Follow-on-Biologics Product Offered
    Table 100. Novartis Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 101. Novartis Main Business
    Table 102. Novartis Latest Developments
    Table 103. Synthon Pharmaceuticals Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 104. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Offered
    Table 105. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 106. Synthon Pharmaceuticals Main Business
    Table 107. Synthon Pharmaceuticals Latest Developments
    Table 108. Teva Pharmaceutical Industries Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 109. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Offered
    Table 110. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 111. Teva Pharmaceutical Industries Main Business
    Table 112. Teva Pharmaceutical Industries Latest Developments
    Table 113. LG Life Sciences Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 114. LG Life Sciences Biosimilars/Follow-on-Biologics Product Offered
    Table 115. LG Life Sciences Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 116. LG Life Sciences Main Business
    Table 117. LG Life Sciences Latest Developments
    Table 118. Celltrion Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 119. Celltrion Biosimilars/Follow-on-Biologics Product Offered
    Table 120. Celltrion Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 121. Celltrion Main Business
    Table 122. Celltrion Latest Developments
    Table 123. Biocon Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 124. Biocon Biosimilars/Follow-on-Biologics Product Offered
    Table 125. Biocon Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 126. Biocon Main Business
    Table 127. Biocon Latest Developments
    Table 128. Hospira Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 129. Hospira Biosimilars/Follow-on-Biologics Product Offered
    Table 130. Hospira Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 131. Hospira Main Business
    Table 132. Hospira Latest Developments
    Table 133. Merck Group Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 134. Merck Group Biosimilars/Follow-on-Biologics Product Offered
    Table 135. Merck Group Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 136. Merck Group Main Business
    Table 137. Merck Group Latest Developments
    Table 138. Biogen idec, Inc. Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 139. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Offered
    Table 140. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 141. Biogen idec, Inc. Main Business
    Table 142. Biogen idec, Inc. Latest Developments
    Table 143. Genentech (Roche Group) Basic Information, Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors
    Table 144. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Offered
    Table 145. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 146. Genentech (Roche Group) Main Business
    Table 147. Genentech (Roche Group) Latest Developments
List of Figures
    Figure 1. Picture of Biosimilars/Follow-on-Biologics
    Figure 2. Biosimilars/Follow-on-Biologics Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Biosimilars/Follow-on-Biologics Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global Biosimilars/Follow-on-Biologics Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Biosimilars/Follow-on-Biologics Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Human Growth Hormone
    Figure 10. Product Picture of Erythropoietin
    Figure 11. Product Picture of Monoclonal Antibodies
    Figure 12. Product Picture of Insulin
    Figure 13. Product Picture of Interferon
    Figure 14. Product Picture of Granulocyte-Colony Stimulating Factor
    Figure 15. Product Picture of Peptide
    Figure 16. Product Picture of Others
    Figure 17. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type in 2021
    Figure 18. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2017-2022)
    Figure 19. Biosimilars/Follow-on-Biologics Consumed in Blood Disorders
    Figure 20. Global Biosimilars/Follow-on-Biologics Market: Blood Disorders (2017-2022) & (K Pcs)
    Figure 21. Biosimilars/Follow-on-Biologics Consumed in Oncology Diseases
    Figure 22. Global Biosimilars/Follow-on-Biologics Market: Oncology Diseases (2017-2022) & (K Pcs)
    Figure 23. Biosimilars/Follow-on-Biologics Consumed in Chronic and Autoimmune Diseases
    Figure 24. Global Biosimilars/Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2017-2022) & (K Pcs)
    Figure 25. Biosimilars/Follow-on-Biologics Consumed in Growth Hormone Deficiencies
    Figure 26. Global Biosimilars/Follow-on-Biologics Market: Growth Hormone Deficiencies (2017-2022) & (K Pcs)
    Figure 27. Biosimilars/Follow-on-Biologics Consumed in Others
    Figure 28. Global Biosimilars/Follow-on-Biologics Market: Others (2017-2022) & (K Pcs)
    Figure 29. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2017-2022)
    Figure 30. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application in 2021
    Figure 31. Biosimilars/Follow-on-Biologics Revenue Market by Company in 2021 ($ Million)
    Figure 32. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company in 2021
    Figure 33. Global Biosimilars/Follow-on-Biologics Sales Market Share by Geographic Region (2017-2022)
    Figure 34. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Geographic Region in 2021
    Figure 35. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2017-2022)
    Figure 36. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Country/Region in 2021
    Figure 37. Americas Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
    Figure 38. Americas Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
    Figure 39. APAC Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
    Figure 40. APAC Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
    Figure 41. Europe Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
    Figure 42. Europe Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
    Figure 43. Middle East & Africa Biosimilars/Follow-on-Biologics Sales 2017-2022 (K Pcs)
    Figure 44. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue 2017-2022 ($ Millions)
    Figure 45. Americas Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021
    Figure 46. Americas Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021
    Figure 47. United States Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Canada Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Mexico Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Brazil Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 51. APAC Biosimilars/Follow-on-Biologics Sales Market Share by Region in 2021
    Figure 52. APAC Biosimilars/Follow-on-Biologics Revenue Market Share by Regions in 2021
    Figure 53. China Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Japan Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 55. South Korea Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Southeast Asia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 57. India Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Australia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021
    Figure 60. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021
    Figure 61. Germany Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 62. France Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 63. UK Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Italy Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 65. Russia Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Middle East & Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country in 2021
    Figure 67. Middle East & Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country in 2021
    Figure 68. Egypt Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 69. South Africa Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 70. Israel Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 71. Turkey Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 72. GCC Country Biosimilars/Follow-on-Biologics Revenue Growth 2017-2022 ($ Millions)
    Figure 73. Manufacturing Cost Structure Analysis of Biosimilars/Follow-on-Biologics in 2021
    Figure 74. Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
    Figure 75. Industry Chain Structure of Biosimilars/Follow-on-Biologics
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Biosimilars/Follow-on-Biologics Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Biosimilars/Follow-on-Biologics Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Biosimilars/Follow-on-Biologics Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports